The Rotronic Monitoring System is a modular system of hardware elements and web-based software. It provides maximum flexibility in installation and ensures readily available data. The data loggers record measurements from Rotronic and third-party sensors and transmit them to the secure database. It stores information and makes it available to users, regardless of whether they access the database via a PC, Mac, tablet or smartphone.
RMS LOGINThe Rotronic Monitoring System is one of the most flexible monitoring systems available on the market today. From small applications with one measurement point to larger systems with several thousand measurement points, RMS offers tailor-made solutions. Existing hardware can be integrated into the Rotronic system and, vice versa, Rotronic hardware can be incorporated into existing software. According to your wishes and requirements for a continuous monitoring system.
With the continuous monitoring system RMS Rotronic meets the requirements of "IoT" and "M2M". Internet of Things (IoT) and machine to machine (M2M) communication are main factors in the design principles of Industry 4.0 that was introduced in 2011 at the Hannover Fair in Germany. The design principle is interoperability, where sensors, devices, machines and people can connect and communicate.
An IoT ecosystem is built up with sensors, that transmit data via a gateway to the Internet. The data is then stored in a certified datacentre. With software, the data is then analysed and again via the Internet, the analysed data can be sent out to remote devices.
This leads to another design principle which is decentralised decision making. From the remote devices and analytics, decisions can be made and commands can be sent, once again via Internet to the IoT devices. The remote devices allow for a third design principle: technical assistance. Services can be carried out directly from the results of the measurement devices.
GxP stands for "Good Practice" guidelines and regulations that apply to various fields such as manufacturing (GMP), laboratory (GLP), and clinical (GCP) settings. Environmental monitoring is crucial in these environments to ensure product safety, integrity, and efficacy. It helps prevent contamination, ensure consistent quality, and maintain compliance with regulatory standards.
Failure to implement environmental monitoring can lead to:
COVID-19 Vaccine Storage Issues (2020-2021) Case: During the global rollout of COVID-19 vaccines, temperature control became a critical issue, particularly for mRNA vaccines like Pfizer-BioNTech and Moderna, which required ultra-cold storage conditions. Several incidents were reported where improper storage temperatures led to vaccine doses being deemed unusable. In one instance, in Wisconsin, hundreds of doses of the Moderna vaccine had to be discarded after they were “stored” at too high a temperature. Impact: Loss of valuable vaccine doses during a critical period, delays in vaccine distribution, and increased costs. Link Insulin Storage and Transportation Failures (Multiple Incidents) Case: Insulin, a temperature-sensitive drug, has been involved in several incidents where improper storage or transportation conditions led to degradation. For example, a study found that up to 93% of insulin deliveries experienced temperature excursions, with some instances leading to compromised efficacy. Impact: Compromised efficacy of insulin, potential harm to patients relying on the drug, product recalls, and significant financial losses. Link Humidity Control Failures in Pharmaceutical Production (2018) Case: A major pharmaceutical manufacturer faced significant challenges due to humidity control issues in their production facility. In 2018, the FDA issued a warning to a pharmaceutical company after it was found that high humidity levels in their manufacturing area led to the degradation of an active pharmaceutical ingredient (API) in one of their drugs. This issue resulted in the contamination of batches and a subsequent product recall. Impact: Product recalls, financial losses, regulatory scrutiny, and potential risks to patient safety due to compromised drug quality. Link These cases highlight the critical importance of maintaining proper temperature and humidity controls in environments where sensitive pharmaceutical products are handled, stored, or manufactured.
Companies can prevent these issues by:
Regulatory bodies like the FDA, EMA, and WHO have stringent guidelines on environmental monitoring in GxP-regulated environments. These guidelines typically require: